Amedisys to Present at the 31st Annual J. P. Morgan Healthcare Conference
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and
hospice care companies, today announced that Ronald A. LaBorde,
President and Chief Financial Officer, will present at the 31st
Annual J. P. Morgan Healthcare Conference in San Francisco, CA on
Wednesday, January 9, 2013.
The presentation will begin at 10:00 a.m. Pacific/1:00 p.m. Eastern. To
access a live webcast of the Amedisys presentation, please log on
through our website at http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. (NASDAQ: AMED) is a leading health care at home company
delivering personalized home health and hospice care to more than
360,000 patients each year. Amedisys is focused on delivering the care
that is best for our patients, whether that is home-based recovery and
rehabilitation after an operation or injury, care focused on empowering
them to manage a chronic disease, palliative care for those with a
terminal illness, or hospice care at the end of life. The Company's
state-of-the-art advanced chronic care management programs and
leading-edge technology enables it to deliver quality care based upon
the latest evidence-based best practices. Amedisys is a recognized
innovator, being one of the first in the industry to equip its
clinicians with point-of-care laptop technology and referring physicians
with an internet portal that enables real-time coordination of patient
care seamlessly. Amedisys also has the industry's first-ever nationwide
Care Transitions program, designed to reduce unnecessary hospital
readmissions through patient and caregiver health coaching and care
coordination, which starts in the hospital and continues throughout
completion of the patient's home health plan of care. For more
information about the Company, please visit: http://www.amedisys.com.
Our company website address is http://www.amedisys.com.
We use our website as a channel of distribution for important company
information. Important information, including press releases, analyst
presentations and financial information regarding the Company is
routinely posted on and accessible on the "Investor Relations" subpage
of our website, which is accessible by clicking on the tab labeled
"Investors" on our website home page. We will also use our website to
expedite public access to time-critical information regarding the
Company in advance of or in lieu of distributing a press release or a
filing with the Securities and Exchange Commission ("SEC") disclosing
the same information. In addition, we make available on the Investor
Relations subpage of our website (under the link "SEC filings") free of
charge our annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and
any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business
Conduct and the charters for the Audit, Compensation and Nominating and
Governance Committees of our Board are also available on the Investor
Relations subpage of our website (under the link "Corporate Governance").
